Showing 1 - 13 results of 13 for search 'E. V. Lubennikova', query time: 0.03s
Refine Results
-
1
Role of Post-Neoadjuvant therapy with trastuzumab emtansine in HER2-positive breast cancer by E. V. Lubennikova, Ya. V. Vishnevskaya
Published 2021-12-01
Article -
2
Alpelisib therapy: from theory to practice by E. V. Lubennikova, T. A. Titova, I. P. Ganshina
Published 2022-06-01
Article -
3
Ixabepilone: new perspectives for its use in breast cancer by A. A. Mescheryakov, E. V. Lubennikova, M. E. Abramov
Published 2018-11-01
Article -
4
-
5
-
6
Ribociclib in 1st line HR+ breast cancer treatment by L G Zhukova, I P Ganshina, O O Gordeeva, E V Lubennikova
Published 2018-06-01
Article -
7
-
8
Olaparib in the metastatic HER2-negative breast cancer setting by L. G. Zhukova, E. I. Khatkova, I. P. Ganshina, I. V. Kolyadina, E. V. Lubennikova
Published 2020-12-01
Article -
9
-
10
Soft tissue metastases of the gluteal region in HER2+ breast cancer: a clinical case by I V Kolyadina, I P Ganshina, L G Zhukova, A G Abdullaev, Yu Yu Andreeva, T Yu Danzanova, G T Sinyukova, D V Komov, N A Kozlov, D A Filonenko, O O Gordeeva, E V Lubennikova
Published 2017-12-01
Article -
11
EXPERIENCE WITH SUBCUTANEOUS TRASTUZUMAB USED IN RUSSIAN FEDERATION by E. V. Lubennikova, I. P. Ganshina, A. N. Lud, D. V. Komov, I. V. Kolyadina, Y. V. Vishnevskaya, I. K. Vorotnikov, D. L. Stroyakovsky, N. A. Savelov, V. F. Semiglazov, А. G. Manikhas, А. V. Osheychik, T. B. Strelnikova, K. R. Zeynalova, L. G. Zhukova
Published 2017-11-01
Article -
12
Efficacy and safety of cisplatin and paclitaxel (PlaTax regimen) in the neoadjuvant treatment of patients with stage II–III triple-negative breast cancer by O. O. Gordeeva, I. V. Kolyadina, L. G. Zhukova, I. P. Ganshina, G. V. Vyshinskaya, M. A. Kazantseva, M. V. Sukhova, O. E. Ryabishina, E. V. Lubennikova, D. A. Filonenko, E. I. Chichikov, I. N. Polushkina, E. I. Borisova, A. N. Lud, A. A. Meshcheryakov
Published 2020-11-01
Article -
13
Russian multicenter experience of using talazoparib in the treatment of patients with BRCA-associated metastatic breast cancer by T. Yu. Semiglazova, E. V. Lubennikova, L. V. Bolotina, R. V. Orlova, F. V. Moiseenko, A. V. Avramenko, E. V. Artemeva, S. A. Borozdina, A. A. Vakhitova, N. M. Volkov, I. P. Ganshina, Sh. A. Dzhalilova, L. G. Zhukova, B. S. Kasparov, A. A. Kachmazov, V. V. Klimenko, A. i. Kornietskaya, A. A. Meshcheryakov, A. A. Paichadze, A. N. Poltoratsky, O. E. Ryabishina, M. L. Stepanova, E. N Imyanitov
Published 2020-12-01
Article